GENE ONLINE|News &
Overview of the Gene Therapy Revolution: Hopeful Beginnings, Tribulations, and Resurgence
Gene therapy is a hot commodity in the biopharma business, attracting profitable investments and expensive M&A transactions in recent years.
Moreover, the frequent reports of research breakthroughs and clinical trial gains are an indication of the steady progress of the field. In 2019, the gene therapy market was valued at $3.61 billion. It is predicted to grow further at a CAGR of 33.6% and reach $35.67 billion by 2027, according to a forecast released by Fortune Business Insights™.
Moreover, the frequent reports of research breakthroughs and clinical trial gains are an indication of the steady progress of the field. In 2019, the gene therapy market was valued at $3.61 billion. It is predicted to grow further at a CAGR of 33.6% and reach $35.67 billion by 2027, according to a forecast released by Fortune Business Insights™.
